Physician profile
Abhishek Thandra
NPI 1730632894
$5,852.29
in general payments reported to CMS, 2019-2025
24 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.67 · 2020: $17.13 · 2021: $814 · 2022: $1,115 · 2023: $2,961 · 2024: $555 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,102 · Food and Beverage: $1,770 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,102.47 |
| Food and Beverage | $1,769.90 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,280.25 | 2021-2023 | Supera |
| Edwards Lifesciences Corporation | $888.71 | 2023 | |
| Medtronic, INC. | $601.27 | 2021-2023 | Onyx Frontier, Telescope |
| Boston Scientific Corporation | $468.00 | 2021-2024 | Avvigo Guidance System, Varithena Administration Pack |
| Penumbra, INC. | $328.45 | 2024-2025 | Indigo System |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Inari Medical, INC. | $136.73 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Teleflex LLC | $124.92 | 2022 | |
| Pfizer INC. | $117.41 | 2020-2025 | |
| Chiesi USA, INC. | $112.07 | 2022-2024 | Kengreal |
| Ge Healthcare | $100.21 | 2022 | |
| Nuwellis, INC. | $75.23 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.85 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.43 | 2025 | |
| Amgen INC. | $47.62 | 2022-2024 | Repatha |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cathworks, INC. | $44.96 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.89 | 2023-2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $40.19 | 2022 | |
| Bracco Diagnostics INC. | $39.39 | 2025 | |
| Novartis Pharmaceuticals Corporation | $36.44 | 2024-2025 | |
| Terumo Medical Corporation | $34.56 | 2022 | |
| Abiomed | $29.02 | 2025 | |
| Merck Sharp & Dohme LLC | $22.02 | 2025 | Verquvo |
| Fresenius USA Marketing, INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhishek Thandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.